Start with its own history
At 2.51×, EMBC is 74.1% below its 4-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NASDAQ · EMBCMedical - Instruments & SuppliesUpdated Nov 4, 2026
Embecta Corp. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
2.51×
74.1% belowthe 4-observation annual average
Share price6.52
÷Earnings per share2.6
Price and EPS in quote currency. Calculation details
Investors are paying 2.51 for every 1 of reported earnings per share.
P/E over time
2022 – 2025
Annual P/ESelected-period average 9.68×
3-year average10.45×3 positive annual observations
5-year average9.68×4 positive annual observations
10-year average9.68×4 positive annual observations
Peer median · TTM34.48×1 peers with positive P/E
Historical P/E ratios
Annual period-end data · 4 observations
| Period end | P/E | Change |
|---|---|---|
| Sep 30, 2025 | 8.60× | -18.2% |
| Sep 30, 2024 | 10.52× | -14.0% |
| Sep 30, 2023 | 12.24× | +66.6% |
| Sep 30, 2022 | 7.34× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How EMBC compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 EMBC This stockEmbecta Corp. | 2.51× |
 CDNACareDx, Inc | 34.48× |
 SIGASIGA Technologies, Inc. | N/M |
 EBSEmergent BioSolutions Inc. | N/M |
 AQSTAquestive Therapeutics, Inc. | N/M |
 MYGNMyriad Genetics, Inc. | N/M |
 VIRVir Biotechnology, Inc. | N/M |
 EVHEvolent Health, Inc. | N/M |
 MRVIMaravai LifeSciences Holdings, Inc. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does EMBC’s P/E tell you?
Compare like with like
The median of the 1 positive peer ratios above is 34.48×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take EMBC into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("EMBC", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 6.52 ÷ EPS 2.6 = 2.51×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
EMBC P/E ratio: common questions
The essentials behind the numbers.
Embecta Corp.'s current P/E is 2.51× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.